Company Overview: NMUS

Industry News

17 Jul

NEMUS Bioscience Announces NB2222 Pain and Anti-Addiction Data Accepted for Presentation at Upcoming Society of Neuroscience Meeting

COSTA MESA, CA–(Marketwired – Jul 17, 2017) – NEMUS Bioscience, Inc. ( OTCQB :NMUS ) announced that data recently obtained from the company’s research and development partner, the University of Mississippi (UM), was accepted for presentation at the 2017 Annual Meeting of the Society of Neuroscience held in Washington, D.C. on November 11th-15th. The data...

Read more

Enter your email address to receive notifications of new posts by email.

Latest Tweets


Follow this blog

Get every new post delivered right to your inbox.

Email address